孤儿药物开发:挑战,监管和成功案例
Narendra Chirmule1, Huije Feng, Esha Cyril
1SymphonyTech Biologics, Philadelphia, USA.
Journal of biosciences
|February 22, 2024
概括
在印度开发用于罕见疾病的孤儿药物面临重大障碍. 建议采用利用新技术的多方合作战略,以克服挑战并加速孤儿药物开发.
科学领域:
- 医学科学 医学科学 医学科学
- 遗传学 遗传学 是一个
- 公共卫生政策 公共卫生政策
背景情况:
- 罕见疾病,或孤儿疾病,影响小人群,由于资源有限和试验参与者,造成发展挑战.
- 基因组学,细胞/基因疗法和调控科学方面的进步导致了一些潜在的治愈性孤儿药物的批准.
- 印度庞大的人口和资源限制给孤儿药物开发带来了独特的困难.
研究的目的:
- 在印度背景下分析孤儿药物开发的挑战.
- 探索最近政策变化对印度罕见病生态系统的影响.
- 为加强印度的孤儿药物开发提出战略方法.
主要方法:
- 全球和印度关于孤儿药物开发的现有文献的审查.
- 对监管进步的分析,包括美国孤儿药物法案和n-of-one试验.
- 构想一个涉及政府,行业和患者团体的协作框架.
主要成果:
- 虽然印度已经实施了一些政策,但对于孤儿药物仍然缺乏明确的监管途径.
- 国际模型,就像美国FDA的方法一样,提供了洞察力,特别是n-of-one试验.
- 印度罕见疾病的金融,科学和临床试验资源存在重大差距.
结论:
- 合作,多方位的方法是必不可少的,涉及政府,监管机构,行业和患者倡导团体.
- 利用快速发展的技术和创新的商业模式可以加速孤儿药物开发.
- 这一战略不仅可以使印度受益,还可以使其他面临类似挑战的资源有限的国家受益.
更多相关视频
相关概念视频
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:02Prescription, Nonprescription and Orphan Drugs
728
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
728
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:26Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158